COMP <GO>
SXT vs BCPC // REVENUE GROWTH (YOY)
Sensient Technologies Corporation (NYSE) VS. Balchem Corporation (NASDAQ) • 15-METRIC TALLY: SXT 4
— BCPC 9
▲ REVENUE GROWTH (YOY) LEADER: BCPC
LAST: $131.53 (-0.05%) • MKT CAP: $5.60B
revenue-growth
3.50%
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
revenue-growth
8.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SXT VS. BCPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SXT | BCPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.50% | 35.70% | -2.20 | BCPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | 14.00% | -5.20 | BCPC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.1x | 25.5x | -3.40 | SXT | /valuation <GO> |
| Free Cash Flow Yield | 0.69% | 4.00% | -3.31 | BCPC | /fcf-yield <GO> |
| Operating Margin | 12.80% | 20.20% | -7.40 | BCPC | /operating-margins <GO> |
| Net Profit Margin | 8.30% | 14.90% | -6.60 | BCPC | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 3.50% | 8.80% | -5.30 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.24% | 0.52% | +0.72 | SXT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.73 | 9.67 | -3.94 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.2 | 50.4 | +0.77 | SXT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.7x | 32.6x | +6.10 | BCPC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.60B | $5.41B | $183.4M | SXT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SXT REV | BCPC REV | SXT GROSS % | BCPC GROSS % | SXT FCF | BCPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.61B | $1.04B | 33.5% | 35.7% | $38.4M | $216.6M |
| FY 2024 | $1.56B | $953.7M | 32.6% | 35.3% | $97.9M | $182.0M |
| FY 2023 | $1.46B | $922.4M | — | — | $104.2M | $183.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SXT // BETA 1.13
BCPC // BETA —